Hide metadata

dc.contributor.authorBornholdt, Jette
dc.contributor.authorFriis, Stine
dc.contributor.authorGodiksen, Sine
dc.contributor.authorPoulsen, Steen S
dc.contributor.authorSantoni-Rugiu, Eric
dc.contributor.authorBisgaard, Hanne C
dc.contributor.authorLothe, Inger M
dc.contributor.authorIkdahl, Tone
dc.contributor.authorTveit, Kjell M
dc.contributor.authorJohnson, Egil
dc.contributor.authorKure, Elin H
dc.contributor.authorVogel, Lotte K
dc.date.accessioned2015-10-09T01:01:07Z
dc.date.available2015-10-09T01:01:07Z
dc.date.issued2011
dc.identifier.citationBMC Cancer. 2011 Feb 10;11(1):65
dc.identifier.urihttp://hdl.handle.net/10852/46226
dc.description.abstractBackground Compromised epithelial barriers are found in dysplastic tissue of the gastrointestinal tract. Claudins are transmembrane proteins important for tight junctions. Claudins regulate the paracellular transport and are crucial for maintaining a functional epithelial barrier. Down-regulation of the oncogenic serine protease, matriptase, induces leakiness in epithelial barriers both in vivo and in vitro. We found in an in-silico search tight co-regulation between matriptase and claudin-7 expression. We have previously shown that the matriptase expression level decreases during colorectal carcinogenesis. In the present study we investigated whether claudin-7 expression is likewise decreased during colorectal carcinogenesis, thereby causing or contributing to the compromised epithelial leakiness of dysplastic tissue. Methods The mRNA level of claudin-7 (CLDN7) was determined in samples from 18 healthy individuals, 100 individuals with dysplasia and 121 colorectal cancer patients using quantitative real time RT-PCR. In addition, immunohistochemical stainings were performed on colorectal adenomas and carcinomas, to confirm the mRNA findings. Results A 2.7-fold reduction in the claudin-7 mRNA level was found when comparing the biopsies from healthy individuals with the biopsies of carcinomas (p < 0.001). Reductions in the claudin-7 mRNA levels were also detected in mild/moderate dysplasia (p < 0.001), severe dysplasia (p < 0.01) and carcinomas (p < 0.01), compared to a control sample from the same individual. The decrease at mRNA level was confirmed at the protein level by immunohistochemical stainings. Conclusions Our results show that the claudin-7 mRNA level is decreased already as an early event in colorectal carcinogenesis, probably contributing to the compromised epithelial barrier in adenomas.
dc.language.isoeng
dc.rightsBornholdt et al; licensee BioMed Central Ltd.
dc.rightsAttribution 2.0 Generic
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/
dc.titleThe level of claudin-7 is reduced as an early event in colorectal carcinogenesis
dc.typeJournal article
dc.date.updated2015-10-09T01:01:07Z
dc.creator.authorBornholdt, Jette
dc.creator.authorFriis, Stine
dc.creator.authorGodiksen, Sine
dc.creator.authorPoulsen, Steen S
dc.creator.authorSantoni-Rugiu, Eric
dc.creator.authorBisgaard, Hanne C
dc.creator.authorLothe, Inger M
dc.creator.authorIkdahl, Tone
dc.creator.authorTveit, Kjell M
dc.creator.authorJohnson, Egil
dc.creator.authorKure, Elin H
dc.creator.authorVogel, Lotte K
dc.identifier.doihttp://dx.doi.org/10.1186/1471-2407-11-65
dc.identifier.urnURN:NBN:no-50424
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/46226/1/12885_2010_Article_2559.pdf
dc.type.versionPublishedVersion
cristin.articleid65


Files in this item

Appears in the following Collection

Hide metadata

Attribution 2.0 Generic
This item's license is: Attribution 2.0 Generic